INTRODUCTION
A lthough with decreasing incidence and mortality in many countries in the last decades, gastric cancer is still common worldwide and its prognosis is poor [1] [2] [3] [4] . Gastrectomy is the only potentially curative treatment, but it is associated with increased postoperative catabolism and metabolic, endocrine, neuroendocrine and immune changes that contribute to high postoperative morbidity rates [5] [6] .
Patients with gastric cancer have a high risk of malnutrition, with a weight loss greater than 10%
in the last six months reported in 30% to 38% of cases 5 . Malnutrition, defined as a state of deficiency of energy, protein and other specific nutrients, has a negative impact on clinical outcome, with a longer hospital stay and increased mortality 7 . A thorough screening for malnutrition is very important, since preoperative nutritional interventions can restore nutritional status and improve surgical outcomes [8] [9] [10] [11] .
However, nutritional assessment is known to be particularly difficult, since none of the currently used methods or instruments alone or in combination have proven to be adequate to increase its sensitivity and specificity [11] [12] [13] .
Regarding evaluation of therapy, no quality measure is as precise, easily quantifiable and important as postoperative mortality 1 . Thirty-day mortality (30DM) is the commonly used parameter, but 90-day mortality (90DM) has been increasingly recognized as a more reliable indicator in many surgical procedures, since 30DM is believed to underestimate total mortality in cases of debilitating, aggressive and advanced tumors of the upper gastrointestinal tract 14 .
The objective of this study was to prospectively evaluate the method of nutritional evaluation that best predicts mortality in 90 days of patients undergoing gastrectomy for gastric cancer.
METHODS
We carried out a prospective study based on a convenience sample that included 44 patients, We evaluated the nutrition status of all patients through the same protocol, up to 72 hours after hospital admission. The parameters used were the Patient-Generated Subjective Global Assessment (PGSGA), classical anthropometry, current weight and height, percentage of weight loss (%WL) and body mass index (BMI). We also measured the thickness of the thumb adductor muscle (TAM) in both hands, dominant hand (TAMD) and non-dominant one (TAM-ND). The laboratory profile included serum levels of albumin, erythrocytes, hemoglobin, hematocrit, leukocytes, and total lymphocytes count (TLC). We calculated the prognostic nutritional index (PNI) using the following formula: 10x serum albumin value (g/dl)
+ 0.005 x total lymphocytes count in the peripheral blood (per mm 3 ) 6 .
We used Portuguese-validated versions of the PGSGA, adapted by Ottery 15 , specific for cancer patients, to evaluate the nutritional status. These results were categorically classified as A, B or C, for well nourished, moderately or severely malnourished, respectively. We used the sum of the scores to determine specific nutritional approaches 16 . We routinely checked the current weight and height with a pre-calibrated platform-type digital scale and a measuring rod.
We used the tables proposed by Lipschitz et al. 16 Regarding the TAM thickness, there was no statistically significant difference observed between the dominant and non-dominant hands (p<0.02). The TAM thickness in the dominant hand (TAMD) was the best parameter capable of predicting death ( Table 2) . All patients who died within the first three postoperative months were significantly more malnourished as demonstrated by the TAMD (Table 2) . Although albumin was decreased in the malnourished patients who died, no laboratory method predicted 90-day mortality with statistical strength (Table 3) . 
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The consumptive process occurs according to a cascade of events and is independent of the size of the surgical procedure, which explains the most expressive and evidenced mortality in the most malnourished patients 10 . Anastomosis dehiscence in patients with poorer nutritional status and with more advanced age is an independent factor of worse prognosis 19 , considerably worsening the incidence of postoperative death in patients with gastric tumor.
Significant weight loss is generally seen in patients with incurable solid tumors 8, 20 , as observed in our results. Gavazzi et al. 21 found weight loss over 5% in the previous three months in 35% of patients recently diagnosed with gastric carcinoma. Rey-Ferro et al. 22 found an average of 10% weight loss, and in those who died postoperatively, weight loss had been significantly higher than in those who survived (p=0.06). These results were also confirmed in the study by Shim et al. 6 , in which preoperative weight loss (p=0.008) and gastric cancer (p<0.001)
were independent risk factors for severe malnutrition.
Recently, Gonzalez et al. 23 reported that TAM thickness was significantly associated with nutritional status in a sample of surgical patients in southern Brazil. We found similar results, the lowest TAM thickness being related to higher mortality, as also demonstrated by Melo and Silva 24 in 151 elective procedures and Bragagnolo 25 in 87 large procedures of the upper gastrointestinal tract, all in Brazil.
In the present study, almost two-thirds (67%) of the patients were malnourished by PGSGA, similar to other studies, showing malnutrition rates of 66% and 57% 26, 27 , but lower than the 86% and 88% described in other works [24] [25] . Paceli et al. 28 found a preoperative weight loss greater than 10% in 42% of gastric cancer patients, similar to those of other Asian studies, of 13% and 31% 6, 7 , respectively. However, this incidence may increase to 81% in the postoperative period, which confirms that gastrectomy significantly affects nutrition 20, 29 .
Probably, these differences between South American and Asian studies are due to differences in the higher prevalence of early stage disease in Asian countries, when nutrition is not yet significantly impaired.
Nutritional status has long been associated with immunocompetence, complications, and infections. Yamanaka et al. 30 , in 1980, demonstrated that serum albumin and prealbumin predicted better preoperative nutritional status than standard anthropometry in 413 patients with gastric cancer (40% of stage IV cases).
In their study, Rey-Ferro et al. 22 argue that hypoalbuminemia and weight loss have a positive predictive value for mortality in patients with gastric cancer. In a multicenter US Gastric Cancer Collaborative study involving 775 patients undergoing gastrectomy, Ejaz et al. 31 observed that BMI < 18.5kg/m 2 and low levels of albumin were related to a significant decrease in overall survival after gastrectomy. However, in our study, it was not possible to significantly associate these parameters with mortality, suggesting that albumin and serum protein parameters may not be as sensitive as anthropometric measures for nutritional status.
The Glasgow prognostic score (GPS) is a significant predictor of long-term survival in patients with curable gastric cancer, but not for short-term evaluations 32, 33 . A Brazilian group found a relationship between PGSGA and GPS, and both measures were associated with postoperative complications and survival in patients with esophageal and stomach cancer 29 . An ongoing study in our research group is evaluating the role of GPS as a short-term predictor of worsening nutritional status and postoperative complications.
The prognostic nutritional index (PNI) has been advocated as a good predictor of postoperative morbidity, prognosis and recurrence patterns in patients in Asian studies 5, 34 . In a recent update of nutrition in patients with gastric cancer, PNI, or a combination of preoperative BMI<18.5kg/m 2 and low albumin levels, appear as predictors of decreased overall survival after gastrectomy 9 . In the present study we did not find statistical significance capable of proving the prediction of mortality.
In our study, 30-day mortality was highly In a study of 751 patients diagnosed with gastrointestinal cancer (51% of gastric cancer), Wu et al. 35 found a higher incidence of complications and longer hospital stay according to the increase in PGSGA levels in patients undergoing surgery or who received chemotherapy/radiotherapy, also observed in our study. The methods evaluated in our study showed a greater prediction of mortality in 30 days. Further studies to determine the best predictors of mortality in 90 days should be performed. On the other hand, the present study indicates that the dominant hand TAM thickness and the PGSGA are reliable prediction parameters of mortality both in 30 and in 90 days in patients submitted to gastrectomy due to stomach cancer.
Objetivos: determinar o método de avaliação nutricional que melhor prediz a mortalidade em 90 dias de pacientes submetidos à gastrectomia por câncer gástrico. Métodos: estudo prospectivo de 44 pacientes portadores de câncer gástrico, estágios II a IIIa, dos quais nove foram submetidos à gastrectomia parcial, 34 à gastrectomia total e um à esôfago-gastrectomia. Todos os pacientes foram avaliados nutricionalmente através do mesmo protocolo, até 72h da admissão hospitalar. Os parâmetros utilizados foram a Avaliação Subjetiva Global Produzida Pelo Paciente (ASG-PPP), antropometria clássica, incluindo peso e altura atuais, porcentagem de perda ponderal (%PP) e índice de massa corporal (IMC). A espessura do músculo adutor do polegar (MAP) em ambas mãos, mão dominante (MAPD) e mão não-dominante (MAPND) também foram realizadas, assim como o cálculo do índice nutricional prognóstico (IPN). O perfil laboratorial incluiu níveis séricos de albumina, eritrócitos, hemoglobina, hematócrito, leucócitos e contagem total de linfócitos (CTL). Resultados: dos 44 pacientes estudados, 29 (66%) eram desnutridos pelo método subjetivo, sendo 15 grau A, 18 grau B e 11 grau C. Os casos com ASG-PPP grau B e com MAPD 10,2±2,9 mm foram significativamente associados à maior mortalidade. As curvas ROC (intervalo de confiança de 95%) de ambas ASG-PPP e espessura da MAPD fidedignamente predisseram mortalidade em 30 e 90 dias. Nenhum método laboratorial permitiu prever a mortalidade em 90 dias. Conclusão: a ASG-PPP e a espessura da MAPD podem ser utilizados como parâmetros pré-operatórios para risco de morte em pacientes submetidos à gastrectomia por câncer gástrico.
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